HOME >> BIOLOGY >> NEWS
Biotech Creates New Solutions And New Problems

Since recombinant DNA techniques were first developed by University of California, San Francisco, and Stanford University scientists in 1973, biotechnology has found commercial application in medicine, food processing and, more recently, agriculture. This year U.S. growers planted 45 million acres of transgenic crops, including herbicide-tolerant, insect- and disease-resistant varieties. But while transgenic crops offer new options for California farmers, they raise questions as well. This issue of California Agriculture explores two of them: how privatization of proprietary rights to key biotechnology will affect public germplasm development, and how the problems of pest resistance may affect the long-term success of larvae-killing transgenic cotton.

Genetic materials ranging from DNA sequences to whole plants, as well as essential biotechnology tools and techniques, are being patented by private and public research entities. At the same time, a series of mergers and acquisitions in the agrochemical and seed industries has led to increasing dominance by a small number of corporations in these fields. Such industrywide changes signal a profound shift in the ownership of life forms and the recombinant DNA tools needed to manipulate them. These changes present problems both for growers of major crops, who find they have an increasingly limited number of suppliers, and growers of minor crops, who may find that transgenic research useful to them is never developed because the potential market is too small.

Plants genetically engineered to produce insecticidal proteins of the bacterium Bacillus thuringiensis provide effective, environmentally safe pest control. However, current transgenic crops have in some cases encountered insect resistance, partly because they have been engineered to produce only a single type of Bt insecticidal protein, and partly because as crop plants age they may produce lower amounts of the Bt protein.


'"/>

Contact: Pam Kan-Rice
pamela.kan-rice@ucop.edu
510-987-0043
University of California - Division of Agriculture & Natural Resources
22-Dec-1998


Page: 1 2 3

Related biology news :

1. Nanosphere announces genetic detection advance in Nature Biotechnology
2. Leroy Hood to receive 2004 Biotechnology Heritage Award
3. Christopher Walsh wins 2004 Promega Biotechnology Research Award
4. Advancing Biotechnology Breakthroughs
5. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
6. Quark Biotech generates a cholesterol-free mouse
7. Army awards up to $50 million to establish Institute for Collaborative Biotechnologies
8. US-EC Biotech Task Force keys on research, collaboration
9. Chemical Heritage Foundation and BIO give Biotechnology Heritage Award to William Rutter
10. Biotechnology taught as a tool for teaching
11. Biotech regulations impede crop domestication

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading provider ... new solution aimed at combatting fraud, waste and abuse ... introduced at the Action on Disaster Relief conference in ... point for UN agencies and foreign assistance organizations throughout ... waste and abuse are a largely unacknowledged problem in ...
(Date:1/25/2017)... The Elements of Enterprise Information Security ... of a comprehensive set of business processes and ... identities and providing a secured and documented access ... number of programs opted by enterprises to maintain ... processes and changing policies. However, there are some ...
(Date:1/24/2017)... 24, 2017  It sounds simple and harmless—an ... monitors vital signs and alerts parents on their ... saturation level drops. But pediatric experts argue that ... with no evidence of medical benefits, especially to ... aggressively to parents of healthy babies, promising peace ...
Breaking Biology News(10 mins):
(Date:2/16/2017)...   Capricor Therapeutics, Inc. (NASDAQ: ... first-in-class biological therapies for cardiac and other medical ... terminate its license agreement with the Mayo Clinic ... "Our decision to return these rights ... efforts to advance our core cell and exosome-based ...
(Date:2/16/2017)...  Champions Oncology, Inc. (NASDAQ: CSBR ), ... advanced technology solutions and products to personalize the development ... of new cohorts of PDX models to their existing ... Champions, product line in hepatocellular cancer, breast cancer, castrate ... non-small cell lung cancer (including EGFR mutation; ALK/ROS1 positive) ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... extended its industry leading Biochemistry Services specifically targeting the rapidly growing needs ... methods for the biochemical and biosimilar characterization , product-related impurity characterization, ...
(Date:2/15/2017)... Inc. (Vanda) (NASDAQ: VNDA), today announced financial and ... year ended December 31, 2016. "2016 ... continued to demonstrate strong growth in our commercial ... Mihael H. Polymeropoulos, M.D., Vanda,s President and CEO. ... milestones underscores Vanda,s commitment to bringing important new ...
Breaking Biology Technology:
Cached News: